News

Researchers find a strong link between Alzheimer's disease and retinal thinning

The DOG recognised Heidelberg Engineering founder Christoph Schoess, Prof Herbert Kaufmann and Prof Ioannis G. Pallikaris

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. Bausch + Lomb is also in the process of seeking regulatory approvals for the lens in additional markets.

AEYE Health will attend the American Academy of Ophthalmology (AAO) Annual Meeting, from October 18-21 in Chicago.

Meeting information to remember, including key locations and childcare options

A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over inadequate screening and management, especially among Black and Hispanic youths.

This patented technology is designed to enhance the light sensitivity of a multi-characteristic opsin developed by Nanoscope as a gene therapy.

The European Association for Vision and Eye Research 27th EVER Congress will be held in Valencia, Spain, November 3 – 5, 2024.

A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over inadequate screening and management, especially among Black and Hispanic youths.

The event will focus on UNITY’s ongoing Phase 2b ASPIRE study, which is evaluating foselutoclax (UBX1325) head-to-head against aflibercept in DME.

This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.

The diverse list of sessions includes discussions of surgical ethics and an arts lecture about Ansel Adams

Applied Science, Inc. (ASI) is expanding its AdaptivMD chronic care workflow technology

MELT-300, a non-IV, non-opioid tablet for procedural sedation during cataract surgery.

The American Academy of Ophthalmology 2024 annual meeting features key lectures and award sessions, highlighting advancements in ophthalmology from leading experts across the field.

The Eye Care Network adds a longstanding, CME-certified conference to its live event programming

On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and finding diseases in the future.

According to the company, MCO-010 is an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic therapy for vision restoration in advanced retinitis pigmentosa (RP), irrespective of gene mutation.

Attendees can choose from symposia, instructional courses, clinical sessions, original papers, skills transfer lectures, the Expo and more

Her Royal Highness will share the CBeebies Bedtime Story "Specs for Rex"

The Eye Care Network adds a longstanding, CME-certified to its live event programming.

The Eye Care Network adds a longstanding, CME-certified conference to its live event programming

Ten of the institute's ophthalmologists will present their work in more than 20 sessions with a wide range of topics

Tinlarebant is an oral therapy designed to reduce the accumulation of vitamin A based toxins that cause retinal disease.